Profound Medical Corp.
PRN.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.18M | -7.98M | -15.70M | -10.72M | -4.95M |
| Total Depreciation and Amortization | 109.00K | 147.00K | 141.00K | 163.00K | 238.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.38M | 1.67M | 1.44M | 1.03M | 502.00K |
| Change in Net Operating Assets | 123.00K | -3.45M | 366.00K | 1.25M | -1.67M |
| Cash from Operations | -6.57M | -9.61M | -13.74M | -8.28M | -5.88M |
| Capital Expenditure | -176.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.00K | -- | -- | -- | -- |
| Cash from Investing | -242.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -290.00K | -741.00K |
| Issuance of Common Stock | 42.44M | -- | -- | -- | 39.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.02M | -- | -- | -- | -3.04M |
| Cash from Financing | 41.43M | 0.00 | 0.00 | -290.00K | 35.44M |
| Foreign Exchange rate Adjustments | 277.00K | -755.00K | 2.51M | 94.00K | -1.77M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.90M | -10.37M | -11.24M | -8.48M | 27.79M |